Ruthigen, Inc., a biopharmaceutical company, and Pulmatrix, Inc., a Lexington, Massachusetts based clinical stage biotechnology company, announced today that on March 13, 2015, they have entered into a definitive merger agreement.
from The Medical News http://ift.tt/1NZvDTg
from The Medical News http://ift.tt/1NZvDTg
No comments:
Post a Comment